Stocktoria
Oaktree Acquisition Corp. III Life Sciences OACC
Oaktree Acquisition Corp. III Life Sciences (OACC) earns a Piotroski F-score of 1/9 (weak financial health), with an Altman Z″ in the distress zone. It does not currently pay a dividend.
How it ranks in Finance, Insurance & Real Estate · percentile among 1129 companies
Percentile vs other Finance, Insurance & Real Estate companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 1/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″ components · distress zone
| Component | Value |
|---|---|
| Working capital / assets | 0.001 |
| Retained earnings / assets | -0.033 |
| EBIT / assets | -0.006 |
| Equity / liabilities | -0.814 |
Sector peers · similar-size Finance, Insurance & Real Estate companies compare side by side →
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| OACC | Oaktree Acquisition Corp. III Life Sciences | 1/9 | -0.99 | 36 | — |
| IPCX | Inflection Point Acquisition Corp. III | 3/9 | -1.27 | 713.8 | — |
| INV | Innventure, Inc. | 4/9 | -2.76 | — | — |
| INNI | Innovaro, Inc. | 1/9 | — | — | -96.4% |
| JFTH | Japan Food Tech Holdings, Inc. | 2/9 | — | — | — |
| MUFG | MITSUBISHI UFJ FINANCIAL GROUP INC | 4/9 | — | — | +9.5% |
| MFG | MIZUHO FINANCIAL GROUP INC | 4/9 | — | — | +7.6% |
All Finance, Insurance & Real Estate companies →
About Oaktree Acquisition Corp. III Life Sciences
Oaktree Acquisition Corp. III Life Sciences does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to target companies in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors in North America and Europe. The company was founded in 1995 and is headquartered in Los Angeles, California.
FAQ
Is OACC financially healthy?
Oaktree Acquisition Corp. III Life Sciences's Piotroski F-score is 1/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the distress zone.
Does OACC pay a dividend?
No, Oaktree Acquisition Corp. III Life Sciences does not currently pay a dividend.
What is OACC's P/E ratio?
Oaktree Acquisition Corp. III Life Sciences's trailing price-to-earnings (P/E) ratio is about 36.0×, based on its latest annual earnings.
Is OACC a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on Oaktree Acquisition Corp. III Life Sciences: a Piotroski F-score of 1/9, an Altman Z″ in the distress zone, a P/E of about 36.0×. Weigh these quality and valuation signals against your own goals.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.